ArticleTranslational lung cancer research2021

SLFN11 biomarker status predicts response to lurbinectedin as a single agent and in combination with ATR inhibition in small cell lung cancer.

Kiran Kundu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.